Search
Co-Diagnostics Inc
CODXAdd to Watchlist
1.440USD
-0.120-7.69%
Close 07-31 16:00（ET）Quotes delayed by 15 min
5.19MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Co-Diagnostics Inc is 6.00, ranking 172 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 1.25, with a high of 1.50 and a low of 1.00.
Analyst Rating
Based on
2
analysts
Hold
Current Rating
30.000
Target Price
+1171.19%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Co-Diagnostics Inc
CODX
2
Intuitive Surgical Inc
ISRG
35
Boston Scientific Corp
BSX
34
Edwards Lifesciences Corp
EW
33
Veeva Systems Inc
VEEV
29
Thermo Fisher Scientific Inc
TMO
29
1
2
3
...
18
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Co-Diagnostics Inc's expected revenue for the next quarter?
Co-Diagnostics Inc's expected revenue is 166.50K.
What is Co-Diagnostics Inc's price target?
Analysts forecast that Co-Diagnostics Inc's price target is USD 1.25, with the highest forecast at USD 1.50 and the lowest forecast at USD 1.00.
How have Co-Diagnostics IncCODX's recent earnings per share performed?
The market expectation was USD -4.06, while Co-Diagnostics IncCODX's earnings per share (EPS) for the previous quarter was USD -13.67. EPS for the next quarter is expected at USD -3.00.
What is the analyst rating for Co-Diagnostics Inc?
Based on the ratings of Co-Diagnostics Inc's stock from 2 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.